Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.70    0.00 (0.00%)
Bid:
0.65
Ask:
0.75
Spread: 0.10 (15.385%)
Market Cap: £3.13m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Results notification

12 Jun 2024 07:00

RNS Number : 0070S
Thruvision Group PLC
12 June 2024
 

12 June 2024

Thruvision Group plc

 

Results notification

 

Thruvision Group plc (AIM:THRU, "Thruvision" or the "Group"), the leading international provider of walk-through security technology, will be publishing its results for the year to 31 March 2024 on Friday 28 June 2024.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

Meare Consulting +44 (0) 7990 858548

Adrian Duffield

 

About Thruvision (www.thruvision.com)

 

Thruvision is the leading developer, manufacturer and supplier of advanced AI-based walk-through security technology internationally. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using advanced AI-based detection algorithms.

The Group's offices are near Oxford and Washington DC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFBMTTMTJBBII
Date   Source Headline
12th Mar 20187:01 amRNSShare Premium Account & Capital Redemption Reserve
12th Mar 20187:00 amRNSTrading Update & Return of Capital
8th Mar 20184:48 pmRNSHolding(s) in Company
27th Feb 20183:21 pmRNSHolding(s) in Company
26th Feb 20184:41 pmRNSSecond Price Monitoring Extn
26th Feb 20184:36 pmRNSPrice Monitoring Extension
18th Jan 20187:00 amRNSAward of Share Options to Executive Directors
20th Dec 201710:48 amRNSDirector Dealing
15th Dec 20177:00 amRNSHalf-year Report
14th Dec 20177:00 amRNSAppointment of Finance Director
13th Dec 20177:00 amRNSNotice of Interim Results
12th Dec 20174:00 pmRNSDirector Dealing
27th Nov 201710:14 amRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirector Dealing
1st Nov 201711:12 amRNSChange of name from Digital Barriers PLC
31st Oct 20173:59 pmRNSCompletion of Disposal
26th Oct 201710:36 amRNSResult of General Meeting
23rd Oct 201710:49 amRNSResult of AGM
12th Oct 20177:00 amRNSProposed disposal: Increased Shareholder Support
9th Oct 20177:00 amRNSProposed disposal of the Video Business
2nd Oct 20173:15 pmRNSHolding(s) in Company
29th Sep 20174:54 pmRNSAnnual Report and Accounts
29th Sep 20177:00 amRNSFinal Results
7th Aug 20177:00 amRNS$11.9 million US Government Contract Award
12th Jul 20174:00 pmRNSChange of Registered Office
12th Jul 20173:30 pmRNSBrimtek deferred consideration
4th May 201711:33 amRNSHolding(s) in Company
2nd May 20177:01 amRNSInvestor Presentation
2nd May 20177:00 amRNSFramework Contract and Trading Update
21st Apr 201711:46 amRNSHolding(s) in Company
20th Apr 20177:00 amRNS$8.0 million US Government Contract Awards
13th Apr 20177:00 amRNSEuropean Framework Contract with G4S
11th Apr 20177:00 amRNSFacial recognition contract with Careem
4th Apr 20174:24 pmRNSHolding(s) in Company
4th Apr 20177:00 amRNSHolding(s) in Company
28th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 201711:08 amRNSSecond Price Monitoring Extn
24th Mar 201711:02 amRNSPrice Monitoring Extension
24th Mar 20177:00 amRNSTrading Update
15th Mar 201710:23 amRNSHolding(s) in Company
10th Mar 201712:26 pmRNSHolding(s) in Company
8th Mar 20175:13 pmRNSHolding(s) in Company
8th Mar 20172:00 pmRNSHolding(s) in Company
8th Mar 20171:58 pmRNSHolding(s) in Company
6th Jan 20177:00 amRNS$7.0m US and Africa Contract Awards
19th Dec 20167:00 amRNS$2.1m ThruVis Contract Award in Middle East
1st Dec 20167:00 amRNSContract wins across APAC and EMEA
29th Nov 20164:37 pmRNSPrice Monitoring Extension
29th Nov 20167:00 amRNSHalf-year Report
23rd Nov 20163:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.